The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 28, 2023

Filed:

Sep. 01, 2022
Applicant:

Rani Therapeutics, Llc, San Jose, CA (US);

Inventors:

Mir Imran, Los Altos Hills, CA (US);

Sara Ansaloni, San Jose, CA (US);

Radhika Korupolu, Fremont, CA (US);

Joel M. Harris, Mountain View, CA (US);

Mir Hashim, Fremont, CA (US);

Assignee:

Rani Therapeutics, LLC, San Jose, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/00 (2006.01); A61K 38/48 (2006.01); A61M 5/172 (2006.01); A61M 5/142 (2006.01); A61M 5/148 (2006.01); A61K 38/37 (2006.01); A61B 5/02 (2006.01);
U.S. Cl.
CPC ...
A61K 9/0065 (2013.01); A61K 9/0024 (2013.01); A61K 38/37 (2013.01); A61K 38/4846 (2013.01); A61M 5/148 (2013.01); A61M 5/14276 (2013.01); A61M 5/1723 (2013.01); A61B 5/02035 (2013.01);
Abstract

Embodiments provide devices, preparations and methods for delivering therapeutic agents (TAs) such as clotting factors (CFs, e.g., Factor 8) within the GI tract. Many embodiments provide a swallowable device e.g., a capsule for delivering TAs into the intestinal wall (IW). Embodiments also provide TA preparations configured to be contained within the capsule, advanced from the capsule into the IW and/or surrounding tissue (ST) and degrade to release the TA into the bloodstream to produce a therapeutic effect (e.g., improved clotting). The preparation can be operably coupled to delivery means having a first configuration where the preparation is contained in the capsule and a second configuration where the preparation is advanced out of the capsule into the IW or ST (e.g., the peritoneal cavity). Embodiments are particularly useful for delivery of CFs for treatment of clotting disorders (e.g., hemophilia) where such CFs are poorly absorbed and/or degraded within the GI tract.


Find Patent Forward Citations

Loading…